Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

News SummaryMost relevantAll newsSector newsTweets 
Latest news on PFIZER INC
06/24 PFIZER : FDA To Discuss Mylotarg Again And Nabriva`s Pivotal Antibiotic Data
06/24 PFIZER : scientists devise 2-pronged attack against blood cancers
06/24 PFIZER : FDA rejects Pfizer`s Epogen biosimilar for the second time
06/24 PFIZER : US FDA rejects Pfizer`s Epogen biosimilar citing McPherson site warning
06/23 ROCHE : Why competition is key to cutting the cost of cancer drugs in South Afri..
06/23 PFIZER : Global Latanoprost Sales Market 2017 - Pfizer, Jamp Pharma, Laboratoire..
06/23 ROCHE : Why Competition Is Key to Cutting the Cost of Cancer Drugs in South Afri..
06/23 PFIZER : boosts corporate brand perceptions
06/22 PFIZER : Global drug firms sign deal to cut cost of cancer medicines in Kenya
06/22 PFIZER : Provides Update on Proposed Epoetin Alfa Biosimilar
06/22 PFIZER : Declares 32-Cent Third-Quarter 2017 Dividend
06/22 PFIZER : New Central Nervous System Agents Findings from Pfizer Described [Abuse..
06/22 PFIZER : and Lilly Receive FDA Fast Track Designation for Tanezumab
06/22 PFIZER : Announces Results from XELJANZ® tofacitinib citrate ORAL Strategy Study..
06/22 PFIZER : Receives Exclusive Commercialization Rights in Europe for CRESEMBA, a N..
06/22 PFIZER : Studies from Pfizer Provide New Data on Thrombosis and Hemostasis (Conf..
06/22 PFIZER : New Biologics Data Have Been Reported by Investigators at Pfizer (Can b..
06/22 PFIZER : New Rheumatoid Arthritis Findings from Pfizer Described (Safety of Tofa..
06/22 PFIZER : kicks off human testing with maternal GBS vaccine
06/21 PFIZER : RMC Pharmaceutical Solutions, Inc. Opens New RTP Regional Office in Nor..
06/21 PFIZER : FDA Reports Critical Drug Shortages
06/21 Sore Throat Remedies Market 2017 - Pfizer, Novartis, Bayer AG, AstraZeneca, P..
06/20 PFIZER : Invites Public To View And Listen To Webcast Of August 1 Conference Cal..
06/20 PFIZER : PFE) Commences Phase 1 Clinical Trial to Evaluate Investigational Group..
06/20DJASTRAZENECA : For AstraZeneca, Cancer Drug Weighs on Go-It-Alone Stand -- WSJ
06/19DJASTRAZENECA : Can AstraZeneca Thrive on Its Own? Big Test Looms
06/19 PFIZER : Begins Phase 1 Clinical Trial to Evaluate Investigational Group B Strep..
06/17 PFIZER : Health Canada warns of shortage of drug used to treat a number of condi..
06/16 PFIZER : Partnerships Drive Progress Toward a Trachoma-Free World
06/16 ROCHE : S/Africa probes multinationals for overpricing drugs
06/16 PFIZER : Basilea bags $72m upfront from Pfizer for antifungal license
06/16 BASILEA PHARMACEUTICA : and Pfizer sign agreement to commercialise IFD treatment..
06/16 PFIZER : FDA fast-tracks Lilly/Pfizer pain drug amid opioid crisis
06/16 PFIZER : NICE rejects Pfizer`s antibody drug for leukaemia
06/16 PFIZER : Announces Results from XELJANZ® (tofacitinib citrate) ORAL Strategy Stu..
06/16 PFIZER : Cancer-drugs probe to go ahead
06/16 Aspen loses Italy appeal over cancer drug prices
06/15 PFIZER : Presents Final Phase 2 Data on Investigational PARP Inhibitor Talazopar..
06/15 PFIZER : Receives FDA Fast Track Designation for Tafamidis for Transthyretin Car..
06/15 ASTELLAS PHARMA : and Pfizer Announce Amendment to Clinical Research Protocol fo..
06/15 PFIZER : New Chronic Lymphocytic Leukemia Study Findings Have Been Reported by R..
06/15 PFIZER : Study Data from Pfizer Update Understanding of Type 2 Diabetes (Once-we..
06/15 SANGAMO THERAPEUTICS : And Pfizer Announce That SB-525 Investigational Hemophili..
06/15 PFIZER : Reports from Pfizer Provide New Insights into Post-Operative Pain (Safe..
06/15 PFIZER : Guardant Health announces broad, long-term alliance with Pfizer Oncolog..
06/15 Cancer drug price increases within allowable limits, says Aspen
06/15 PFIZER : CMA publishes full decision in phenytoin case
06/15 PFIZER : and Lilly receive FDA fast track designation for tanezumab
06/15 PFIZER : denies over-charging cancer drugs
06/15 PFIZER : Drugs firms to be probed
06/15 Watchdog probes Aspen for cancer drug pricing
06/14 PFIZER : Receives Exclusive Commercialization Rights in Europe for CRESEMBA, a N..
06/14 #BADPHARMA : Pharmaceutical companies behind high cost for cancer medication
06/14 PFIZER : Companies probed for drug price fixing
06/14 PFIZER : German Merck Doubles Down On Dual-Acting Cancer Agents
06/14 ROCHE : Competition Commission on investigation into cancer drugs manufacturers
06/13 Progesterone Market 2017 - Pfizer, Solvay, ASEN, SENZU, Actavis, Merck Serono..
06/13 ROCHE : Competition Commission On Investigation Into Cancer Drugs Manufacturers
06/13 PFIZER : Ministry of Health and Prevention signs agreement with Pfizer to protec..
06/13 PFIZER : Merck, Pfizer make their PhIII case for an SGLT2 latecomer to the block..
06/13 PFIZER : hits accelerator on Xtandi trial in early prostate cancer
06/13 PFIZER : Merck, Pfizer covering bases with SGLT2 inhibitor latecomer
06/12DJJOHNSON & JOHNSON : Drug Sales Reel Amid Probe Into Charities -- WSJ
06/12 PFIZER : LXRX Brings Sweet Tidings, PFE's PROSPER Ahead Of Schedule, XBIT Fails ..
06/10 PFIZER : Astellas, Pfizer Announce Amendment to Clinical Research Protocol for P..
06/09 PFIZER : European Commission Approves Pfizer's TRUMENBA® to Help Prevent Meningo..
06/09 PFIZER : Investigators at Pfizer Target Vaccination (Effectiveness of pneumococc..
06/09 PFIZER : Investigators at Pfizer Discuss Findings in Immunoglobulins (Mechanisti..
06/09 CYTOSORBENTS : Dr. Eric G. Mortensen, M.D., Ph.D., Clinical Trial Veteran, Joins..
06/09 PFIZER : Patent Issued for Sildenafil Sublingual Spray Formulations (USPTO 96623..
06/09 PFIZER : Recent Reports from Pfizer Highlight Findings in Venous Thromboembolism..
06/09 PFIZER : Studies from Pfizer Have Provided New Data on Drug Resistance [Evaluati..
06/09 PFIZER : Findings from Pfizer Provides New Data about Sulfur Amino Acids (Target..
1  2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2017 52 736 M
EBIT 2017 19 871 M
Net income 2017 10 814 M
Debt 2017 25 179 M
Yield 2017 3,76%
P/E ratio 2017 17,25
P/E ratio 2018 15,44
EV / Sales 2017 4,34x
EV / Sales 2018 4,03x
Capitalization 203 487 M
More Financials
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 37,4 $
Spread / Average Target 9,3%
Consensus details
EPS Revisions
More Estimates Revisions
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
Mikael Dolsten President-Worldwide Research & Development
Ole Isacson Chief Scientific Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON18.42%367 520
NOVARTIS12.96%225 386
ROCHE HOLDING LTD.8.68%224 497
PFIZER5.20%203 487
MERCK AND COMPANY12.38%180 958
More Results